Page last updated: 2024-10-24

buspirone and Neoplasms

buspirone has been researched along with Neoplasms in 3 studies

Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
" Buspirone, a non-benzodiazepine anxiolytic which does not suppress respiration and has proven efficacy in the treatment of generalized anxiety disorder, has been suggested to relieve the sensation of dyspnea in patients with COPD."9.22Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study. ( Banerjee, TK; Bushunow, PW; Dakhil, SR; Dudgeon, DJ; Flannery, MA; Garland, SN; Heckler, CE; Hopkins, JO; Kirshner, JJ; Morrow, GR; Peoples, AR; Peppone, LL; Roscoe, JA, 2016)
" Buspirone, a non-benzodiazepine anxiolytic which does not suppress respiration and has proven efficacy in the treatment of generalized anxiety disorder, has been suggested to relieve the sensation of dyspnea in patients with COPD."5.22Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study. ( Banerjee, TK; Bushunow, PW; Dakhil, SR; Dudgeon, DJ; Flannery, MA; Garland, SN; Heckler, CE; Hopkins, JO; Kirshner, JJ; Morrow, GR; Peoples, AR; Peppone, LL; Roscoe, JA, 2016)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Takwale, AD1
Jo, SH1
Jeon, YU1
Kim, HS1
Shin, CH1
Lee, HK1
Ahn, S1
Lee, CO1
Du Ha, J1
Kim, JH1
Hwang, JY1
Peoples, AR1
Bushunow, PW1
Garland, SN1
Heckler, CE1
Roscoe, JA1
Peppone, LL1
Dudgeon, DJ1
Kirshner, JJ1
Banerjee, TK1
Hopkins, JO1
Dakhil, SR1
Flannery, MA1
Morrow, GR1

Trials

1 trial available for buspirone and Neoplasms

ArticleYear
Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:3

    Topics: Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Buspirone; Disease Management; Double-Blind Method;

2016

Other Studies

2 other studies available for buspirone and Neoplasms

ArticleYear
Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras.
    European journal of medicinal chemistry, 2020, Dec-15, Volume: 208

    Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Cell Line, Tumor; Humans; Male

2020
Drug watch providing essential information.
    Nursing RSA = Verpleging RSA, 1994, Volume: 9, Issue:8

    Topics: Buspirone; Humans; Lactation; Metronidazole; Neoplasms; Nicotine; Paclitaxel; Substance-Related Diso

1994